576
Participants
Start Date
May 16, 2008
Primary Completion Date
December 22, 2008
Study Completion Date
December 22, 2008
GSK233705 12.5mcg
Once daily via dry powder inhaler
GSK233705 25mcg
once daily via dry powder inhaler
GSK233705 50mcg
Once daily via dry powder inhaler
GSK233705 100mcg
Once daily via dry powder inhaler
GSK233705 200mcg
Once daily via dry powder inhaler
Placebo
Once daily via dry powder imhaler
GSK Investigational Site, Budapest
GSK Investigational Site, Quezon City
GSK Investigational Site, Quezon City
GSK Investigational Site, Sofia
GSK Investigational Site, Parktown
GSK Investigational Site, Balassagyarmat
GSK Investigational Site, Pergamino
GSK Investigational Site, Mátraháza
GSK Investigational Site, San Miguel de Tucumán
GSK Investigational Site, Cavite
GSK Investigational Site, Dimitrovgrad
GSK Investigational Site, Rousse
GSK Investigational Site, Cape Town
GSK Investigational Site, Bellville
GSK Investigational Site, Mar del Plata
GSK Investigational Site, Mowbray
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Bangkok
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Richmond
GSK Investigational Site, Lübeck
GSK Investigational Site, Abingdon
GSK Investigational Site, Charlotte
GSK Investigational Site, Spartanburg
GSK Investigational Site, Union
GSK Investigational Site, Greenville
GSK Investigational Site, Hanover
GSK Investigational Site, Hanover
GSK Investigational Site, Panama City
GSK Investigational Site, South Miami
GSK Investigational Site, Brandon
GSK Investigational Site, Jasper
GSK Investigational Site, Magdeburg
GSK Investigational Site, Khon Kaen
GSK Investigational Site, Madisonville
GSK Investigational Site, Chiang Mai
GSK Investigational Site, Saint Charles
GSK Investigational Site, Gelnhausen
GSK Investigational Site, Wiesloch
GSK Investigational Site, Lafayette
GSK Investigational Site, Sunset
GSK Investigational Site, Houston
GSK Investigational Site, Coeur d'Alene
GSK Investigational Site, Glendale
GSK Investigational Site, Los Angeles
GSK Investigational Site, Los Angeles
GSK Investigational Site, Songkhla
GSK Investigational Site, Riverside
GSK Investigational Site, Fountain Valley
GSK Investigational Site, Fullerton
GSK Investigational Site, Roseville
GSK Investigational Site, Brasov
GSK Investigational Site, Iași
GSK Investigational Site, Valparaíso
GSK Investigational Site, Santiago
GSK Investigational Site, Santiago
GSK Investigational Site, Santiago
GSK Investigational Site, San Diego
GSK Investigational Site, Charleston
GSK Investigational Site, La Plata
GSK Investigational Site, Mar del Plata
GSK Investigational Site, Sofia
GSK Investigational Site, Santiago
GSK Investigational Site, Calgary
GSK Investigational Site, Bay Roberts
GSK Investigational Site, Mississauga
GSK Investigational Site, Ottawa
GSK Investigational Site, Toronto
GSK Investigational Site, Saint Romuald
GSK Investigational Site, Sainte Jerome
GSK Investigational Site, Sainte-Foy
GSK Investigational Site, Dresden
GSK Investigational Site, Schmölln
GSK Investigational Site, Budapest
GSK Investigational Site, Almelo
GSK Investigational Site, Eindhoven
GSK Investigational Site, Hoofddorp
GSK Investigational Site, Hoorn
GSK Investigational Site, Bucharest
GSK Investigational Site, Mueckelneck
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Brighton
GSK Investigational Site, London
GSK Investigational Site, Norwich
Lead Sponsor
GlaxoSmithKline
INDUSTRY